Gut reaction

Michael Eisenstein

Nature, 2018, vol. 563, issue 7730, S34-S35

Abstract: Existing treatments bring only temporary relief to people with ulcerative colitis, a common form of inflammatory bowel disease. Insights into the immunobiology of the condition are driving the development of therapies that could lead to prolonged periods of remission.

Keywords: Cell biology; Immunology; Microbiome (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-018-07277-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:563:y:2018:i:7730:d:10.1038_d41586-018-07277-1

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-018-07277-1

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().